NFKB1 and acute kidney injury: MaR1 effectively inhibited the NOX4/ROS/NF-κB p65 signaling pathway and reduced kidney inflammation, cell apoptosis, oxidative stress and mitochondrial dysfunction, ultimately protecting against LPS-induced AKI (41).